Fecal microbiota transplantation (FMT) has achieved satisfactory results in preventing the
recurrence of Clostridioides difficile infection, but these positive outcomes have only been …

Objectives Current evidence on fecal microbiota transplantation for inflammatory bowel
disease is inconclusive. We conducted a systematic review to gather evidence on the …

Multidrug-resistant organism (MDRO) colonization is a fundamental challenge in
antimicrobial resistance. Limited studies have shown that fecal microbiota transplantation …

In the past decade, fecal microbiota transplantation (FMT) has rapidly spread worldwide in
clinical practice as a highly effective treatment option against recurrent Clostridioides difficile …

Background The gastrointestinal microbiota is the key antigenic drive in the inflammatory
bowel diseases. Randomized controlled trials (RCTs) in ulcerative colitis have established …

Inflammatory bowel diseases represent a complex array of diseases of incompletely known
etiology that led to gastrointestinal tract chronic inflammation. In inflammatory bowel …

With the development of microbiology and metabolomics, the relationship between the
intestinal microbiome and intestinal diseases has been revealed. Fecal microbiota …

Purpose Fecal microbiota transplantation (FMT) has been found to be a potential treatment
for Crohn's disease (CD). We sought to perform a systematic review and meta-analysis to …

Inflammatory bowel disease (IBD) is a chronic intestinal mucosal inflammatory disease with
complex etiology. Traditional anti-inflammatory treatment regimens have yielded …

Background: Reduced microbiota diversity (dysbiosis) in people with HIV (PWH) likely
contributes to inflammation, a driver of morbidity and mortality. We aimed to evaluate the …